Wasn't there always going to be debt draw this quarter with FCF scheduled for the 2nd half of the year.The way I read this it was a very good quarter. What am I missing?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%